Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime E C Hallak

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 11, 2010
The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjectsJaime E C Hallak, Serdar M Dursun, Daniel C Bosi, et al.
Journal of Psychopharmacology (Oxford, England)|November 27, 2009
Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of maniaSamira S Valvassori, Guilherme Elias, Bruna de Souza, et al.
Human Psychopharmacology|February 2, 2022
Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof-of-concept, randomized, placebo-controlled trialsRafael G Dos Santos, Juliana Mendes Rocha, Giordano Novak Rossi, et al.
Frontiers in Pharmacology|October 14, 2016
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in RatsFernanda F Peres, Raquel Levin, Mayra A Suiama, et al.
Journal of Affective Disorders|March 18, 2023
DNA methylation in regulatory elements of the FKBP5 and NR3C1 gene in mother-child binomials with depressionMariana S Mendonça, Paula M Mangiavacchi, Ana V Mendes, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 9, 2011
Adhesio interthalamica alterations in schizophrenia spectrum disorders: A systematic review and meta-analysisClarissa Trzesniak, Matthew J Kempton, Geraldo F Busatto, et al.
Psychopharmacology|July 29, 2022
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?João F C Pedrazzi, Frederico R Ferreira, Danyelle Silva-Amaral, et al.
Schizophrenia Research|October 23, 2010
Are cavum septum pellucidum abnormalities more common in schizophrenia spectrum disorders? A systematic review and meta-analysisClarissa Trzesniak, Irismar R Oliveira, Matthew J Kempton, et al.
Frontiers in Pharmacology|April 4, 2017
Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe EpilepsyRaquel A Do Val-da Silva, Jose E Peixoto-Santos, Ludmyla Kandratavicius, et al.
Frontiers in Pharmacology|June 6, 2022
Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key RecommendationsJosé Diogo S Souza, Maíra Fassoni-Ribeiro, Rayssa Miranda Batista, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 11, 2010
The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjectsJaime E C Hallak, Serdar M Dursun, Daniel C Bosi, et al.
Journal of Psychopharmacology (Oxford, England)|November 27, 2009
Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of maniaSamira S Valvassori, Guilherme Elias, Bruna de Souza, et al.
Human Psychopharmacology|February 2, 2022
Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof-of-concept, randomized, placebo-controlled trialsRafael G Dos Santos, Juliana Mendes Rocha, Giordano Novak Rossi, et al.
Frontiers in Pharmacology|October 14, 2016
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in RatsFernanda F Peres, Raquel Levin, Mayra A Suiama, et al.
Journal of Affective Disorders|March 18, 2023
DNA methylation in regulatory elements of the FKBP5 and NR3C1 gene in mother-child binomials with depressionMariana S Mendonça, Paula M Mangiavacchi, Ana V Mendes, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 9, 2011
Adhesio interthalamica alterations in schizophrenia spectrum disorders: A systematic review and meta-analysisClarissa Trzesniak, Matthew J Kempton, Geraldo F Busatto, et al.
Psychopharmacology|July 29, 2022
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?João F C Pedrazzi, Frederico R Ferreira, Danyelle Silva-Amaral, et al.
Schizophrenia Research|October 23, 2010
Are cavum septum pellucidum abnormalities more common in schizophrenia spectrum disorders? A systematic review and meta-analysisClarissa Trzesniak, Irismar R Oliveira, Matthew J Kempton, et al.
Frontiers in Pharmacology|April 4, 2017
Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe EpilepsyRaquel A Do Val-da Silva, Jose E Peixoto-Santos, Ludmyla Kandratavicius, et al.
Frontiers in Pharmacology|June 6, 2022
Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key RecommendationsJosé Diogo S Souza, Maíra Fassoni-Ribeiro, Rayssa Miranda Batista, et al.
Pageof 13